The drug eluting and Stents (DES) market is predicted to reach USD 8.98 billion by 2026. This is due to the rising incidence of cardiovascular disease in the world. A drug-eluting stent semi-rigid devices that is an elongated tube coated with a substance that prevents recurrence or restonosis of an arterial blockage once released. They aid in reducing the risk of restenosis and reduce the possibility of early or late thrombosis for patients. Further information about the market is available in a recent report from Fortune Business Insights(tm)
For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/drug-eluting-stent-des-market-102612
“Drug Eluting Stents (DES) Market Size, Share & Industry Analysis, By Type (Coronary Stenting, and Peripheral Stenting), By Product (Polymer-based, and Polymer-free), By Scaffold (Cobalt-Chromium, Platinum-Chromium, Nitinol and Others), By Drug (Sirolimus, Paclitaxel, Zotarolimus, Everolimus, and Others), By End User (Hospitals, and Specialty Clinics), and Regional Forecast, 2019-2026.” According to this study, market was US$ 5.71 billion in the year 2019 and will grow by 6.7 percent between 2019 and 2026.
What is the Scope of the Report?
The report provides an overview that covers the entire market as well as its primary growth pathways, such as the drivers, limitations, challenges and opportunities. The report also focuses on the market segmentation according to aspects like the type, the scaffold and drug, as well as the end-user and the regions. It also gives market data and CAGRs for the top segments, along with their attributed causes. In addition, the report sheds the spotlight on the current drug-eluting Stents market trends, major changes in the industry, and fascinating information. Competitive landscape, a list of players on the market, as well as the strategies they employ to achieve the top position on the market are included inside the document. For more information about the report, go to the website of the company.
Market Drivers
Improved Health Infrastructure in developing countries will boost growth
The growing incidences of cardiovascular disease around the world are an important factor in increasing the market in drug-eluting Stents. In addition, the government-backed reimbursement policies and an increase in the amount of money spent on the development and research of improved stents is also contributing to the growth in the size of market. This, in conjunction with FDA acceptances as well as CE certifications received by a variety of stents, is anticipated to boost the use of drug-eluting market for stents over the forecast time.
On the other hand there is a possibility that the market will be faced with challenges regarding recalls of product. However, the introduction of new and technologically advanced treatments are likely to generate huge growth potential for this market over the coming years.
